ICEERS
International Center for Ethnobotanical Education, Research & Service
is Associate Professor of Psychiatry and Neurology at New York University School of Medicine. He is author of over 70 peer-reviewed publications, books and book chapters. His research on iboga alkaloids has combined psychopharmacology and the methodology of medical ethnography, includes a case series on the use of ibogaine for the indication of heroin detoxification, and a recent paper published in the Journal of Ethnopharmacology that combined qualitative and quantitative methods to provide a comprehensive overview on the global use of ibogaine. Dr. Alper is independently supported by the National Institute on Drug Abuse as investigator in the quantitative EEG in cocaine dependence. His published clinical research on the neuropsychiatric aspects of epilepsy has included highly cited work on trauma and abuse in conversion disorder and dissociative symptomatology, and the effect of psychopharmacological treatment on seizure threshold.
received his PhD in Pharmacology in 2003, at the Autonomous University of Barcelona (UAB), with a thesis on the human pharmacology of ayahuasca. He is Associate Professor of Pharmacology at the UAB and Associate Researcher at the Drug Research Center of the Sant Pau Hospital in Barcelona, where he has conducted a series of clinical studies with Ayahuasca, which have assessed its phamacokinetics and pharmacodynamics, including alkaloid disposition, subjective effects and electroencephalography and neuroimaging measures of acute ayahuasca administration. The results have been published in scientific journals such as Psychopharmacology, The Journal of Pharmacology and Experimental Therapeutics, The British Journal of Clinical Pharmacology and The Journal of Psychoactive Drugs. He is currently the lead researcher of a study assessing the effects of long-term ayahuasca use.
Jose Carlos Bouso’s studies addressed preliminary data on the safety and efficacy of different doses of MDMA administered in a psychotherapeutic setting to women with chronic posttraumatic stress disorder (PTSD) secondary to a sexual assault. He also has been develope neuropsychological research about long term effects of ayahuasca use in both Spanish and Brazilian communitties. He currently works in Dr Jordi Riba's team conducting neuropharmacological research on psychedelics.